Sox9 is an essential transcription factor for chondrogenesis by regulating the expression of chondrogenic genes. However, its regulatory mechanism is not fully understood. To address this, we attempted to identify the transcriptional partners of Sox9 by screening the cDNA library of the chondrogenic cell line ATDC5 using the collagen 21 (Col21) gene promoter fused to a luciferase reporter gene. One of the positive clones encoded the Znf219 gene. Whole mount in situ hybridization experiments indicated that Znf219 mRNA was specifically expressed in the developing limb buds where Col21 and Sox9 were strongly expressed. Znf219 markedly enhanced the transcriptional activity of Sox9 on the Col2a1 gene promoter. In addition, Znf219 is physically associated with Sox9 and is colocalized with Sox9 in the nucleus. We also found that overexpression of Znf219 profoundly increased Sox9-induced mRNA expression of Col2a1, aggrecan and Col11a2. Consistently, knockdown of Znf219 decreased the Sox9-induced mRNA expression of these genes. Furthermore, a dominant-negative mutant Znf219 inhibited Bmp2-induced chondrocyte differentiation. Our results suggest that Znf219 plays an important role in the regulation of chondrocyte differentiation as a transcriptional partner of Sox9.
Introduction
Chondrogenesis is an important biological event involved in tissue patterning, skeletal development and endochondral ossification (Shum and Nuckolls, 2002; Kronenberg, 2003; Kobayashi and Kronenberg, 2005) . Chondrogenesis starts from the condensation of multipotent mesenchymal cells and then the cells proliferate and differentiate into chondrocytes. Proliferative chondrocytes secrete chondrogenic matrices, including collagen 21 (Col21), collagen 112 (Col112) and aggrecan, and further differentiate into hypertrophic chondrocytes (de Crombrugghe et al., 2000; de Crombrugghe et al., 2001; Kronenberg, 2006) . Cartilage tissues are finally replaced by bone tissues at the end of chondrogenesis (Provot and Schipani, 2005) . Conversely, some permanent cartilages, including articular cartilage, retain chondrocytes and are never replaced by bone tissues. Transcription factors such as the Sox9 family (Sox9, Sox5 and Sox6) and the Runx2 family (Runx2 and Runx3) play crucial roles in these complex processes Ueta et al., 2001; Akiyama et al., 2002; Akiyama et al., 2004a; Yoshida et al., 2004) .
The transcription factor Sox9, which contains an SRY-related high-mobility group box, promotes the differentiation of mesenchymal cells into chondrocytes and induces the expression of Col21 (Lefebvre et al., 1996; Lefebvre et al., 1997) , Col112 (Bridgewater et al., 1998) and aggrecan (Sekiya et al., 2000) in the chondrocytes (Bi et al., 1999; Bi et al., 2001; Akiyama et al., 2002; Akiyama et al., 2004b; Akiyama et al., 2007) . In human, heterozygous mutations of the Sox9 gene result in campomelic dysplasia characterized by severe chondrodysplasia (Wagner et al., 1994 ; Morais da Silva et al., 1996; Wunderle et al., 1998; McDowall et al., 1999; Giordano et al., 2001; Sock et al., 2003) . Sox9 mutant mice or mice lacking Sox9 function show impaired endochondral bone formation (Bi et al., 1999; Akiyama et al., 2002; Akiyama et al., 2007) . These findings demonstrate that Sox9 plays essential roles in chondrogenesis, particularly in the early stage (Lefebvre et al., 1996; Lefebvre et al., 1997; Lefebvre et al., 1998; Akiyama, 2008) .
Sox9 has been proposed to form a large molecular complex that regulates several processes of gene expression including chromatin remodeling, histone modification, transcription and splicing of the target genes during chondrogenesis (Maniatis and Reed, 2002; Carrozza et al., 2003; Kitagawa et al., 2003; Kameoka et al., 2004) . Sox5 and Sox6 have been shown to regulate the expression of Sox9 target genes as transcriptional partners of Sox9 Akiyama et al., 2002; Smits et al., 2001; Smits et al., 2004; Ikeda et al., 2004) ; however, they have no molecular constitutions to control the nuclear events required for gene expression. Transcriptional coactivators PGC-1 and p300 might regulate chondrogenesis by potentiating Sox9-dependent transcription on chromatinized DNA through the acetylation of histones (Tsuda et al., 2003; Furumatsu et al., 2004; Kawakami et al., 2005) . Recently, p54 nrb has been identified as a member of the Sox9-assembled transcriptional factory and p54 nrb links to Sox9-dependent transcription to control splicing of the target genes of Sox9 (Kameoka et al., 2004; Hata et al., 2008) . These reports have contributed to the identification of transcriptional components for Sox9 that are implicated in To understand the molecular basis by which Sox9 controls chondrogenesis, we have attempted to identify the transcriptional partners of Sox9. We isolated the Znf219 gene, which contains nine zinc finger domains, as a member of the Sox9-assembled transcriptional factory and determined whether Znf219 functionally and physically associates with Sox9 and regulates chondrocyte differentiation. Our data indicate that Znf219 plays an important role in regulation of chondrocyte differentiation as a member of Sox9-assembed transcriptional factory.
Results

Identification of the Znf219 gene by mammalian expression cloning and expression of the Znf219 gene associated with chondrogenesis
To identify the components of the Sox9 transcription factory, we screened a cDNA library of the chondrogenic cell line ATDC5 (Shukunami et al., 1996) using a Col2a1 gene promoter luciferase reporter construct (Muramatsu et al., 2007; Hata et al., 2008) . We identified approximately 50 positive clones that activate Col2a1 gene promoter activity, including Sox5 and Sox6 (Yano et al., 2005; Jin et al., 2006; Glass and Karsenty, 2007; Muramatsu et al., 2007; Hata et al., 2008) . We have also isolated the Znf219 gene, which has not been previously reported as being related to chondrogenesis. Znf219, which was initially isolated from a human testis cDNA library, contains nine C2H2-type zinc finger domains (Sakai et al., 2000) . To examine whether Znf219 is involved in chondrocyte differentiation, we first determined the expression profiles of Znf219 in chondrocytes by performing reverse-transcription polymerase chain reaction analysis (RT-PCR). This analysis indicated that Znf219 mRNA is expressed in primary chondrocytes (Fig. 1A,B) . We also observed that Znf219 is highly expressed in the heart, pancreas and testis, where Sox9 plays an important role (De Santa Barbara et al., 1998; Stolt et al., 2003; Chaboissier et al., 2004; Akiyama et al., 2004a; Lynn et al., 2007) (Fig. 1B) . Furthermore, whole mount in situ hybridization using E11.5 mouse embryos demonstrated that Znf219 is specifically expressed in developing limb buds, where Col2a1 and Sox9 are strongly expressed (Fig. 1C) . In addition, immunocytochemical analyses indicate that Znf219 is predominantly expressed in proliferating chondrocytes as Sox9 (Fig. 1D ). We then examined whether Znf219 expression is associated with chondrocyte differentiation. Znf219 expression was very marginal in a murine mesenchymal cell line, C3H10T1/2 (Fig. 1E) . However, Znf219 expression was markedly upregulated in C3H10T1/2 cells infected with Sox5, Sox6 and Sox9 adenoviruses, which promote chondrocyte differentiation (Fig.  1E) . Conversely, Znf219 overexpression did not affect Sox9 expression (Fig. 1F) . Consistent with Fig. 1E , Znf219 expression is associated with chondrocyte differentiation of ATDC5 cells (Cont) or Znf219 adenoviruses at 20 multiplicity of infection and cultured for 4 days. Total RNA was isolated from the cells and subjected to real-time PCR. (G)ATDC5 cells were cultured for 3, 6, 10 or 14 days in the presence of insulin (10g/ml). Total RNA was isolated from the cells and subjected to real-time PCR using Col2a1 and Znf219 primers. (Fig. 1G) . These results indicate that expression of Znf219 is associated with chondrocyte differentiation and suggest that Znf219 is involved in the regulation of chondrogenesis.
Znf219 stimulates the function of Sox9 by forming a transcriptional complex with Sox9
We next examined whether Znf219 activates the transcriptional activity of Sox9 using a Col2a1 gene promoter luciferase construct containing four repeats of the Sox9 binding element (Muramatsu et al., 2007; Hata et al., 2008) . Znf219 itself clearly stimulated Col2a1 gene promoter activity ( Fig. 2A) . In addition, Venus-tagged Znf219 was localized in the nucleus (Fig. 2B) , suggesting that Znf219 functions as a transcriptional regulator. We also found that Znf219 markedly upregulated the transcriptional activity of Sox9 on the Col2a1 gene promoter (Fig. 2A) . By contrast, a dominant-negative Sox9 markedly inhibited the effect of Znf219 on the Col2a1 gene promoter in C3H10T1/2 cells, where Sox9 is endogenously expressed (Fig. 2C) . However, overexpression of Znf219 had no effect on the transcriptional activity of Runx2, an essential transcription factor for osteogenesis (Komori et al., 1997; Ducy et al., 1997) , and PPAR, a crucial nuclear receptor for adipogenesis (Tontonoz et al., 1994; Wu et al., 1995) (Fig. 2D,E) . These results suggest that Znf219 specifically regulates the transcriptional activity of Sox9. Consistent with these results, Venus-tagged Znf219 was colocalized well with DsRed-tagged Sox9 in the nuclei, but was not colocalized with DsRed-tagged Runx2 (Fig. 3) . Interestingly, Znf219 forms smaller granules in the nuclei when Znf219 is present with Sox9 (Fig. 3B) . Moreover, co-immunoprecipitation experiments showed that Znf219 is physically associated with Sox9 (Fig. 4A) . To further understand the molecular interaction between Znf219 and Sox9, we performed an in vitro binding assay using a series of deletion mutants of Znf219 (Fig. 4B ). As shown in Fig. 4C , the region including the fifth and sixth zinc finger domains is required for the association with Sox9. Conversely, an in vitro binding assay using Sox9 mutants (Fig. 4D ) indicated that the C-terminal region of Sox9 is required for the binding to Znf219 (Fig. 4E ). Taken together, Znf219 forms a transcriptional factory with Sox9, thereby upregulating the function of Sox9, and might be involved in chondrocyte differentiation regulated by Sox9.
Functional role of Znf219 in chondrogenic differentiation
To examine the functional role of Znf219 in chondrocyte differentiation, we overexpressed Znf219 in C3H10T1/2 mesenchymal cells using an adenovirus gene delivery system. Znf219 overexpression dramatically enhanced Sox9-induced mRNA expression of Col2a1, aggrecan and Col11a2 mRNA ( Fig.  5A-C) . By contrast, Znf219 had no effect on Col1a2 expression (Fig. 5D ). These results suggest that Znf219 regulates chondrocyte differentiation of mesenchymal cells through forming a transcription factory with Sox9. To confirm this, we attempted to examine the role of Znf219 in chondrocyte differentiation using a dominantnegative strategy. As shown in Fig. 6A , a mutant of Znf219 (5) inhibited the transcriptional activity of wild-type Znf219 for the Col2a1 gene promoter. The mutant also suppressed the transcriptional activity of Sox9 on the Col2a1 gene promoter (Fig.  6B ). In addition, the Venus-tagged Znf219 5 mutant was colocalized well with DsRed-tagged Sox9 in the nucleus (Fig. 6C ). As shown in Fig. 4C , the binding assay showed a physical interaction between the Znf219 mutant and Sox9. These results suggested that the Znf219 5 mutant functions as a dominantnegative mutant of Znf219. Importantly, we found that overexpression of the Znf219 mutant inhibited Sox9-induced Col2a1, aggrecan and Col11a2 expression (Fig. 6D-F) . Moreover, overexpression of the Znf219 mutant inhibited Bmp2-induced chondrocyte differentiation of C3H10T1/2 cells (Shea et al., 2003) , as determined by Alcian Blue staining (Fig. 6G ). In addition, the mutant of Znf219 inhibited chondrocyte differentiation of limb bud cells in a micromass culture system (Fig. 6H) . Overexpression of the Znf219 mutant inhibited calcification of mouse primary chondrocytes and mouse embryo limb bud cells (Fig. 6I,J) . By contrast, overexpression of the Znf219 mutant did not affect osteoblast differentiation of C3H10T1/2 and C2C12 cells (Fig.  6K,L) . These results indicate that the mutant of Znf219 specifically inhibits chondrocyte differentiation. To further verify these results, we generated synthetic microRNA for Znf219 and examined the effect of knockdown of Znf219. We could clearly knockdown Znf219 after the introduction of microRNA for Znf219 by an adenovirus system (Fig. 7A,B) . Conversely, knockdown of Znf219 by microRNA system had no significant effects on endogenous Sox9 expression (Fig. 7B) . Knockdown of Znf219 inhibited Sox9-induced expression of Col2a1, aggrecan Col11a2, Sox5 and Sox6 (Fig. 7C-G) . These results support the importance of Znf219 in chondrocyte differentiation.
Znf219 regulates Col2a1 expression through two copies of GGGGG motifs
To understand the molecular mechanism by which Znf219 regulates chondrocyte differentiation, we attempt to identify the binding 3784 Journal of Cell Science 123 (21) domain of Znf219 for the Col2a1 gene. A previous study reported that Znf219 regulates the target genes through the GGGGG motif (Sakai et al., 2003) . We found that two copies of GGGGG motifs are present in the Col2a1 gene promoter region (Fig. 8A) . To address whether Znf219 regulates the Col2a1 gene expression through these GGGGG motifs, we generated mutants of the Col2a1 gene promoter luciferase construct (Fig. 8B) . The mutations in the Col2a1 gene suppressed the transcriptional activity of Znf219 (Fig.  8C) . These results suggested that Znf219 regulates Col2a1 expression through these GGGGG motifs.
To confirm whether Znf219 directly binds to these regions of the Col2a1 promoter, we performed a pull-down assay using an oligonucleotide probe containing the GGGGG motifs. We found that Znf219 directly bound to the GGGGG motifs and this association was abolished by an unlabelled competitive probe (Fig.  8D) . We have revealed that Znf219 functions as a transcriptional activator for the Col2a1 promoter by recognizing two copies of the GGGGG motif. Collectively, our results suggest that Znf219 functions as a molecular component of the transcription factory formed by Sox9 in the promotion of chondrocyte differentiation and plays an important role in chondrocyte differentiation. Mouse limb bud cells were infected with control or Znf2195 adenovirus and then subjected to micromass culture in the presence or absence of Bmp2 (100g/ml). After 10 days, the cells were stained with Alizarin Red. (K)No effect of Znf2195 on Bmp2-induced osteoblast differentiation in C3H10T1/2 cells was seen. C3H10T1/2 cells infected with control (Cont) or Znf2195 adenovirus were cultured in the presence or absence of Bmp2 (100g/ml) for 7 days and subjected to alkaline phosphatase staining. (L)No effect of Znf2195 on Bmp2-induced osteoblast differentiation in C2C12 cells was seen. C2C12 cells infected with control (Cont) or Znf2195 adenovirus were cultured in the presence or absence of Bmp2 (100g/ml) for 4 days and subjected to alkaline phosphatase staining.
Discussion
Transcription factors sequentially and harmoniously regulate the expression of target genes by forming a large complex with the partner molecules. To better understand the process of Sox9-regulated chondrogenesis, we attempted to identify the transcriptional partner of Sox9. As a result of performing the mammalian expression cloning, we have identified Znf219 as an interacting partner of Sox9. We showed that Znf219 not only physically, but also functionally, associates with Sox9 during chondrogenesis. First, the overexpression of Znf219 stimulates the transcriptional activity of Sox9 and its chondrogenic action. Second, Znf219 colocalized well with Sox9 and formed much smaller granules in the nucleus when Sox9 was present. The size of nuclear speckle has been shown to be inversely correlated with the state of transcription of the cells (Lamond and Spector, 2003) ; therefore, it is probable that interaction of Znf219 with Sox9 stimulates its transcriptional activity. Third, knockdown or inhibition of Znf219 markedly suppressed chondrocyte differentiation. Collectively, Znf219 is an important transcriptional factory member of Sox9 during chondrocyte differentiation.
We showed that Znf219 had no effect on osteoblast differentiation from mesenchymal cells. In addition, Znf219 does not interact and colocalize with Runx2. Moreover, Znf219 overexpression had little effect on expression of Col1a2, an osteoblastic marker. Therefore, Znf219 seems to selectively regulate chondrocyte differentiation of undifferentiated mesenchymal cells. To support this, Znf219 was specifically expressed in the developing limb buds of the mouse embryo and the proliferative chondrocytes of mouse growth plate. Furthermore, expression of Znf219 is upregulated during chondrocyte differentiation, probably through Sox9 family members. Conversely, Znf219 does not appear to function as upstream of Sox9 as overexpression or knockdown of Znf219 did not affect Sox9 expression. Because the physiological role of Znf219 in vivo is still unclear, it is necessary to perform the experiments using an appropriate in vivo model. Therefore, we believe that analyses of
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Znf219-deficient mice will contribute to the better understanding of Znf219 in endochondral ossification. It has been shown that Sox9 plays crucial roles in the development of the heart and testis (Akiyama et al., 2004a; Wagner et al., 1994 ). Because we observed that Znf219 was also highly expressed in hearts and testis, Znf219 might be involved in development of heart and testis in association with Sox9. Znf219-deficent mice would be a good model to investigate the role for Znf219 in these organs.
It has been reported that Znf219 recognizes the GGGGG motif as the DNA binding element and functions as a transcriptional repressor for the Hmgn1 gene promoter activity (Sakai et al., 2003) . We also showed that Znf219 binds to a GGGGG motif present in the Col2a1 gene promoter. Interestingly, potential Znf219 binding sites were found in the promoter region of the aggrecan and Col11a2 gene promoters as well as the Col2a1 gene. In contrast to a previous publication (Sakai et al., 2003) , our data indicate that Znf219 functions as a transcriptional activator for the Col2a1 gene promoter. It is therefore probable that Znf219 has a function as a transcriptional regulator to control not only negatively, but also positively, according to the binding molecule. It has been shown that Hmgn1 binds to the Sox9 gene and inhibits Sox9 expression and chondrogenesis (Furusawa et al., 2006) . Together, it is hypothesized that Znf219 negatively regulates chondrogenesis through the upregulation of Hmgn1. However, we did not observe that Znf219 affects Hmgn1 expression in C3H10T1/2 cells (data not shown). Thus, it is unlikely that Znf219 forms a negative-feedback loop with Hmgn1.
The Znf219 mutant that lacks the last zinc finger domain shows the strongest dominant-negative effect on wild-type Znf219. This mutant still associates with Sox9 and retains the ability to bind to the Col2a1 gene promoter region. As expected, the mutant markedly inhibited Bmp2-induced chondrocyte differentiation in C3H10T1/2 cells and mouse limb bud cells. It is therefore probable that the last zinc finger domain of Znf219 is necessary for chondrogenesis to recruit important transcriptional partners of Sox9 and Znf219. The concept is compatible with the structural feature that Znf219 contains nine sets of zinc finger domains but does not contain other domains involved in transcription, chromatin remodeling and histone modification. Thus, Znf219 might function as an adaptor protein that links Sox9 to transcriptional events. Several studies have demonstrated that transcription factors exert their activities through docking with co-regulatory factors (Kornberg and Lorch, 1999; Dallas et al., 2000; Emerson, 2002; Wilsker et al., 2004) . Although the precise biochemical role of Znf219 in chondrogenesis is unknown, identification of molecules associated with the last zinc finger domain of Znf219 might allow further understanding of the molecular mechanisms by which Sox9 regulates chondrogenesis.
In conclusion, our data provide evidence that Znf219 functions as a molecular component of the transcription factory formed by Sox9 during the promotion of chondrocyte differentiation. These findings contribute to a better understanding of chondrogenesis conducted by Sox9.
Materials and Methods
Cells and reagents
A murine chondrogenic cell line (ATDC5), a murine mesenchymal cell line (C3H10T1/2) and a human kidney cell line (BOSC23) were obtained from the RIKEN Cell Bank (Ibaragi, Japan) and cultured in a 1:1 mixture of Dulbecco's Modified Eagle's Medium (DMEM) and Ham's F-12 medium (Sigma) containing 10% fetal bovine serum (FBS). C2C12, CHO-K1 and COS7 cell lines were purchased from the RIKEN Cell Bank and cultured in alpha-modified minimal essential medium (-MEM) containing 10% FBS. These cell cultures were performed at 37°C in a humidified 5% CO 2 incubator. Recombinant Bmp2 was obtained from the conditioned medium of CHO-K1 cells infected with Bmp2 adenovirus. The activity of Bmp2 was determined by a comparison with human recombinant Bmp2.
Micromass culture of mouse limb bud cells
Limb bud cells were isolated from embryonic day (E) 11.5 DDY mouse embryos and mass cultured as described previously (Carlberg et al., 2001) . Briefly, the anterior and posterior limb buds of E11.5 mouse embryos were pooled and digested with DMEM containing 0.1% collagenase type II (collagenase from Clostridium histolyticum, type II, Sigma) and 0.1% trypsin (trypsin, type I, from bovine pancreas, Sigma) at 37°C. The cells were dissociated by pipetting and then centrifuged at 300 g for 5 minutes. The pellet was resuspended in DMEM with 10% FBS at a density of 2ϫ10 7 cells/ml. A total of 2ϫ10 5 cells/20 l of cell suspension was placed in a 12-well plate at 37°C in a humidified 5% CO 2 incubator for 2 hours then 2 ml of culture medium was added to the wells. Twelve hours later, the cells were treated with infection of adenoviruses and administration of Bmp2 (100 g/ml) and the culture medium was replaced every other day thereafter. Cell differentiation was assessed by Alcian Blue and Alizarin Red staining.
Isolation and culture of mouse primary chondrocytes
Primary chondrocytes were isolated from the ribs of 4-week-old DDY mice and repetitively digested with 0.2% collagenase at 37°C. The fractioned cells were filtered by 40 m nylon mesh (BO Bioscience), collected by centrifugation and used as primary chondrocytes, except for the cells from the first digestion (Gartland et al., 2005) . The cell culture was performed in DMEM supplemented with 10% bovine serum albumin, 0.1 mg/ml ascorbic acid, 5 mM -glycerophosphate (Sigma) and 10% FBS at 37°C in a humidified 5% CO 2 incubator. Infection of adenoviruses and administration of Bmp2 (100 g/ml) were performed after 2 days.
Whole mount in situ hybridization
C57BL/6 mouse embryos (at E11.5) were fixed in 4% paraformaldehyde in PBS overnight at 4°C, treated with 6% hydrogen peroxide in PBS for 30 minutes, washed with PBS, incubated in 20 mg/ml proteinase K in PBS for 15 minutes, post-fixed with 4% paraformaldehyde and 0.2% glutaraldehyde in PBS for 20 minutes, washed twice for 5 minutes in PBS, washed twice for 5 minutes in hybridization solution (50% formamide, 5ϫSSC, pH 7.0, 2% blocking-reagent, 50 g/ml yeast tRNA, 0.1% Triton X-100, 0.1% CHAPS, 5 mM EDTA, 50 g/ml heparin), incubated at 70°C in hybridization solution for 1 hour and hybridized overnight with a genespecific RNA probe. Post-hybridization washes were done in Solution I (50% formamide, 5ϫSSC, pH 4.5, 0.1% Triton X-100, 0.1% CHAPS), Solution II (50% formamide, 2ϫSSC, pH 7.0) and KTBTx (10 mM KCl, 150 mM NaCl, 50 mM TrisHCl, pH 7.0, 0.1% Triton X-100, 10ϫKTB). Embryos were pre-blocked with 1.5% blocking reagent and KTBTx for 1 hour. After pre-blocking of anti-DIG in the mouse embryo, embryos were incubated overnight at room temperature. Whole-day post-antibody washes were done using KTBTx. Visualization began with a brief rinse in NTMTx (0.1 M NaCl, 0.1 M Tris-HCl, pH 9.5, 50 mM MgCl 2 , 0.1% Triton X-100) and continued according to the manufacturer's instructions (NBT/BCIP). When the reaction was judged complete, embryos were post-fixed and photographed using a microscope.
Immunocytochemical analyses
Paraffin sections of E15.5 mouse tibia were prepared and immunostained with polyclonal rabbit antibodies: -Znf219 antibody (Abcam, ab71279) at 1:500 dilution, and -Sox9 (Santa Cruz Biotechnology, H-90) at 1:500 dilution. Immunoreactivity was visualized with a biotinylated anti-rabbit IgG secondary antibody using the ABC Vectastain Kit (Vector) and the peroxidase substrate DAB Kit (Vector) according to the manufacturer's protocol.
Constructs and transfection
Venus cDNA, a variant of green fluorescent protein, was a kind gift from Dr Atsushi Miyawaki (RIKEN). Mutations of Znf219 were generated by subcloning of the corresponding polymerase chain reaction (PCR) products into pcDNA3 tagged with Flag, Myc and Venus. Deletion mutants of Znf219 were generated by subcloning the corresponding PCR products into pcDNA3 tagged with a Flag epitope in the N-terminus. HA-tagged Sox9 and dominant-negative Sox9 (aa21-234) cDNA were kindly provided by Dr Vincent Harley (Prince Henry's Institute of Medical Research, Australia). HA-tagged HMG mutant Sox9 (aa181-510) was used as described previously (Hata et al., 2008) . Transfection of C3H10T1/2 cells was carried out using FuGENE6 (Roche, Indianapolis, IN) according to the manufacturer's protocol.
Generation of adenovirus
The recombinant adenoviruses carrying a wild-type of Sox9, Sox5 and Sox6 or a mutant form of Znf219 were constructed by homologous recombination between the expression cosmid cassette (pAxCAwt) and the parental virus genome in 293 cells using an adenovirus construction kit (Takara, Tokyo, Japan), as previously described (Hata et al., 2008; Amano et al., 2009) . The viruses showed no proliferative activity owing to a lack of E1A-E1B. Infection of recombinant adenoviruses into C3H10T1/2 cells, C2C12 cells, mouse limb bud cells or mouse primary chondrocytes was performed by incubation with the adenoviruses at a multiplicity of infection (moi) of 20, except where specifically indicated.
Knockdown of Znf219
Znf219 microRNA was obtained using the BLOCK-iT Pol II miR RNAi Expression System (Invitrogen). The target sequence was: 5Ј-TGCTGTTCATGTGG TT -Regulation of chondrogenesis by Znf219 CTTAAGGAACGTTTTGGCCACTGACTGACGTTCCTTAAACCACATGAA-3Ј. The microRNA for the Znf219 construct was infected into C3H10T1/2 cells using an adenovirus system.
Immunoprecipitation and western blotting
The cells were washed three times with ice-cold PBS and solubilized in lysis buffer [20 mM HEPES (pH 7.4) , 150 mM NaCl, 1 mM EGTA, 1.5 mM MgCl 2 , 10% glycerol, 1% Triton X-100, 10 g/ml of aprotinin, 10 g/ml of leupeptin, 1 mM phenylmethylsulfonyl fluoride (PMSF), 0.2 mM sodium orthovanadate]. The lysates were then centrifuged for 15 minutes at 4°C at 16,000 g and with antibodies for 16 hours at 4°C, followed by immunoprecipitation with protein G-agarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Immunoprecipitates were washed five times with lysis buffer and boiled in sodium dodecyl sulfate (SDS) sample buffer containing 0.5 M -mercaptoethanol for 5 minutes. The supernatants were recovered as immunoprecipitate samples. These samples were separated by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose membranes, immunoblotted with corresponding antibodies and visualized with horseradish peroxidase coupled to anti-mouse rabbit IgG antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) with enhancement by Electrochemiluminescence (ECL) Advance Western Blotting Detection Kits (Amersham).
Luciferase reporter gene assay
The luciferase reporter construct driven by the Col2a1 gene promoter was cotransfected with the thymidine kinase-renilla luciferase construct (Promega) into C3H10T1/2 cells. Two days after transfection, the cells were lysed and luciferase activity was determined using specific substrates in a luminometer (Promega) according to the manufacturer's protocol. Transfection efficiency was normalized by determining the activity of renilla luciferase.
Reverse-transcriptase PCR and real-time PCR
Total RNA was isolated from cells and treated with DNase using a commercial total RNA isolation system (NucleoSpin RNAII, MACHEREY-NAGLE, Germany). After denaturation of total RNA at 70°C for 10 minutes, cDNA was synthesized using an oligo-dT primer and reverse transcriptase (Prime Script 1st Strand cDNA Synthesis Kit, Takara, Japan). Amplifications were performed using the specific primers for -actin (sense primer: 5Ј-TTCGAGCAGGAGATGGCCAC-3Ј; anti-sense primer: 5Ј-TCTGCATCCTGTCAGCAAT-3Ј), Col2a1 (sense primer: 5Ј-TATGGAAGCCCT-CATCTTGC-3Ј; anti-sense primer: 5Ј-TCACCTCTGGGTCCTTG TTC-3Ј), aggrecan (sense primer: 5Ј-TCCTCTCCGGTGGCAAAGAAGTTG-3Ј; anti-sense primer: 5Ј-CCAAGTTCCAGGGTCACTGTTACCG-3Ј) or Znf219 (sense primer: 5Ј-AGTAC-GACCCAAATGGTGAGG-3Ј; anti-sense primer: 5Ј-GGTGCAGGGAAGTCAGA-GAG-3Ј). Amplification products were loaded onto agarose gel and stained with ethidium bromide. Real-time PCR was performed by the Taqman PCR protocol using the ABI 7300 real-time PCR system (Applied Biosystems, Branchburg, NJ, USA). Taqman primers and probes used for amplification were as follows: -actin (probe: CCTGGCTGCCTCA ACACCTCAACCC-TAMURA; sense primer: 5Ј-TTAATT -TCTGAA TGGCCC AGGTCT-3Ј; anti-sense primer: 5Ј-ATTGGTCTCAAGTCAGT-GTACAGG-3Ј), Col2a1 (probe: TGAGGTTGCCAGCCGCTTCGTCCA-TAMURA; sense primer: 5Ј-CCTCCGTCTACTGTCCACTGAG-3Ј; anti-sense primer: 5Ј-TGGAGCCCTG GATGAGCAAG-3Ј), aggrecan (probe: ACCGTCTCTCCGCATC-CACCCAGG-TAMURA; sense primer: 5Ј-TCACTGTTACCGCCACTTTCC-3Ј; anti-sense primer: 5Ј-TGCTGCTCAGATGTGACTGC-3Ј), Col11a2 (probe: CCCCA-GAAGCACCCCTCCCCGTC-TAMURA; sense primer: 5Ј-GATGCCTCCT -TCGCAGACCT-3Ј; anti-sense primer: 5Ј-CCTAGCCCATGAAGCAGACAG-3Ј), Znf219 (probe: TGTCCCTCCAACC AGCAGCCCGTT-TAMURA; sense primer: 5Ј-GGGACCCAGGCGAGATCC-3Ј; anti-sense primer: 5Ј-CACGGCCCGCTTCA-GATC-3Ј), Sox5 (probe: ACGTTGGGCAACAAGCACAGATCCCC-TAMURA; sense primer: 5Ј-AGGCAGGAAATGCGACAGTAC-3Ј; anti-sense primer: 5Ј-CTCG-GAGGGCAGGTGAGG-3Ј), Sox6 (probe: TCAGCAGCAGCGTTCACGAGCAGC-TAMURA; sense primer: 5Ј-TACCCACAGCTCCCCTGAAG-3Ј; anti-sense primer: 5Ј-CTCACCTTCAGTGGCAAGAGC-3Ј), Col11a2 (probe: AGTCTCCTCCCTTG-GCCCCTCCCC-TAMURA; sense primer: 5Ј-CAGAGCAGTGTGCAATATGATCC-3Ј; anti-sense primer: 5Ј-ATGTCCACAACAGGTGTCAGG-3Ј) and Sox9 (probe: CCGCCCATCACCCGCTCGCAATAC-TAMURA; sense primer: 5Ј-CCTTCAAC-CTTCCTCACTACAGC-3Ј; anti-sense primer: 5Ј-GGTGGAGTAGAGCCCTGAGC-3). Expression levels of mRNA were normalized by -actin mRNA expression.
In vitro binding assay using recombinant His-tagged Sox9 protein and Znf219
The amplification product containing the coding region of Sox9 was subcloned into pCold1 vector (Takara). The construct was transformed into the BL21 E. coli strain and then His-tagged Sox9 protein was generated and purified with Ni-NTA magnetic agarose beads (QIAGEN) according to the manufacturer's protocol. The purified His-tagged Sox9 protein immobilized with the beads was used for the binding assay with Znf219. The association of Sox9 with mutants of Flag-tagged Znf219 was determined by immunoblotting with anti-Flag antibody, following precipitation of cell lysates with the recombinant His-tagged Sox9 protein. To determine the association of Znf219 with mutant Sox9 in vitro, Znf219-Myc protein immobilized on Dyna Protein G beads were incubated with cell lysates expressing HA-tagged wild-type, dominant-negative or HMG mutant Sox9 for 2 hours. Proteins associated with Znf219-Myc were determined by immunoblotting with anti-HA antibody.
Oligonucleotide precipitation assay
Cells were lysed in lysis buffer [20 mM HEPES (pH 7.4), 150 mM NaCl, 1 mM EGTA, 1.5 mM MgCl 2 , 10% glycerol, 1% Triton X-100, 10 g/ml leupeptin, 1 mM PMSF, 0.2 mM sodium orthovanadate]. The lysates pre-incubated with streptavidinagarose beads were incubated with 1 g of a biotinylated double-stranded oligonucleotide probe that contained two repeats of the Znf219 binding element present in the Col2a1 gene promoter (sense primer: 5Ј-CCAGCTGGGGGCAG -GGGGCGGCCCGCG-3Ј; anti-sense primer: 5Ј-CGCGGGCCGCCCCCTGCCCC -CAGCTG-3Ј) and 1 g of poly(dI-dC)poly(dI-dC) for 16 hours. DNA-bound proteins were collected with streptavidin dynabeads (Dynabeads My One Streptavidin T1, Invitrogen) for 1 hour, washed with the lysis buffer, separated on an SDSpolyacrylamide gel and identified by western blotting.
Alcian Blue staining
The cells were rinsed twice with PBS, fixed in 4% buffered paraformaldehyde and stained with 1% Alcian Blue in 5% acetic acid for 10 minutes.
Alizarin Red staining
The cells were cultured in the presence of ascorbic acid (100 g/ml) and -glycerophosphate (5 mM), rinsed twice with PBS, fixed in 4% buffered paraformaldehyde and stained with 1% Alizarin Red solution for 5 minutes.
Alkaline phosphatase staining
The cells were washed with PBS, fixed with 3.7% formaldehyde and stained with a mixture of 330 g/ml Nitro Blue Tetrazolium, 165 g/ml bromochloroindoyl phosphate, 100 mM NaCl, 5 mM MgCl 2 and 100 mM Tris (pH 9.5).
Fluorchrome staining
C3H10T1/2 cells were transfected with Venus-Znf219, DsRed-Sox9, or DsRedRunx2. Cultured cells were washed three times with ice-cold PBS and fixed with 10% paraformaldehyde in PBS for 10 minutes. After incubation for 20 minutes with 0.2% Triton X-100 in PBS, the cells were blocked with PBS containing 1% bovine serum albumin for 1 hour, incubated with 0.1 mg/ml DAPI in PBS containing 1% bovine serum albumin, then washed with 0.2% Triton X-100 in PBS and visualized by a fluorescence microscope (Zeiss).
Statistical analysis
The data were statistically analyzed by Student's t-test or analysis of variance. Data represent mean ± s.d.
